L1CAM is also overexpressed in various types of human cancer, including gynecological tumors, such as ovarian cancer and EC [8,9,10,11], linked to poor prognosis, aggressive and invasive phenotype, advanced disease stages, metastasis, and resistance to chemotherapy [8,9,10]. This evidence concerns the gene L1CAM and ovarian carcinoma.